Literature DB >> 10982365

Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by rac1 and phosphatidylinositol-3 kinase activation.

S Sanlioglu1, P K Benson, J Yang, E M Atkinson, T Reynolds, J F Engelhardt.   

Abstract

Adeno-associated virus (AAV) is a single-stranded DNA parvovirus that causes no currently known pathology in humans. Despite the fact that this virus is of increasing interest to molecular medicine as a vector for gene delivery, relatively little is known about the cellular mechanisms controlling infection. In this study, we have examined endocytic and intracellular trafficking of AAV-2 using fluorescent (Cy3)-conjugated viral particles and molecular techniques. Our results demonstrate that internalization of heparan sulfate proteoglycan-bound AAV-2 requires alphaVbeta5 integrin and activation of the small GTP-binding protein Rac1. Following endocytosis, activation of a phosphatidylinositol-3 (PI3) kinase pathway was necessary to initiate intracellular movement of AAV-2 to the nucleus via both microfilaments and microtubules. Inhibition of Rac1 using a dominant N17Rac1 mutant led to a decrease in AAV-2-mediated PI3 kinase activation, indicating that Rac1 may act proximal to PI3 kinase during AAV-2 infection. In summary, our results indicate that alphaVbeta5 integrin-mediated endocytosis of AAV-2 occurs through a Rac1 and PI3 kinase activation cascade, which directs viral movement along the cytoskeletal network to the nucleus.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10982365      PMCID: PMC102117          DOI: 10.1128/jvi.74.19.9184-9196.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  64 in total

Review 1.  Integrin-mediated signalling: regulation by protein tyrosine kinases and small GTP-binding proteins.

Authors:  J T Parsons
Journal:  Curr Opin Cell Biol       Date:  1996-04       Impact factor: 8.382

2.  Cdc42 and Rac1 induce integrin-mediated cell motility and invasiveness through PI(3)K.

Authors:  P J Keely; J K Westwick; I P Whitehead; C J Der; L V Parise
Journal:  Nature       Date:  1997-12-11       Impact factor: 49.962

Review 3.  Rho, Rac and Cdc42 GTPases regulate the organization of the actin cytoskeleton.

Authors:  N Tapon; A Hall
Journal:  Curr Opin Cell Biol       Date:  1997-02       Impact factor: 8.382

4.  Insulin-like growth factor receptor cooperates with integrin alpha v beta 5 to promote tumor cell dissemination in vivo.

Authors:  P C Brooks; R L Klemke; S Schon; J M Lewis; M A Schwartz; D A Cheresh
Journal:  J Clin Invest       Date:  1997-03-15       Impact factor: 14.808

Review 5.  Viral manipulations of the actin cytoskeleton.

Authors:  S Cudmore; I Reckmann; M Way
Journal:  Trends Microbiol       Date:  1997-04       Impact factor: 17.079

6.  Recombinant adeno-associated virus for muscle directed gene therapy.

Authors:  K J Fisher; K Jooss; J Alston; Y Yang; S E Haecker; K High; R Pathak; S E Raper; J M Wilson
Journal:  Nat Med       Date:  1997-03       Impact factor: 53.440

7.  Role of tyrosine phosphorylation of a cellular protein in adeno-associated virus 2-mediated transgene expression.

Authors:  K Qing; X S Wang; D M Kube; S Ponnazhagan; A Bajpai; A Srivastava
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

8.  Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis.

Authors:  K J Fisher; G P Gao; M D Weitzman; R DeMatteo; J F Burda; J M Wilson
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

9.  Translational diffusion of macromolecule-sized solutes in cytoplasm and nucleus.

Authors:  O Seksek; J Biwersi; A S Verkman
Journal:  J Cell Biol       Date:  1997-07-14       Impact factor: 10.539

10.  Regulation of cell motility by mitogen-activated protein kinase.

Authors:  R L Klemke; S Cai; A L Giannini; P J Gallagher; P de Lanerolle; D A Cheresh
Journal:  J Cell Biol       Date:  1997-04-21       Impact factor: 10.539

View more
  82 in total

1.  Adeno-associated virus type 2-mediated gene transfer: altered endocytic processing enhances transduction efficiency in murine fibroblasts.

Authors:  J Hansen; K Qing; A Srivastava
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

Review 2.  Pathways of cell infection by parvoviruses and adeno-associated viruses.

Authors:  Maija Vihinen-Ranta; Sanna Suikkanen; Colin R Parrish
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

3.  Parvovirus infection of cells by using variants of the feline transferrin receptor altering clathrin-mediated endocytosis, membrane domain localization, and capsid-binding domains.

Authors:  Karsten Hueffer; Laura M Palermo; Colin R Parrish
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

4.  Cross-dressing the virion: the transcapsidation of adeno-associated virus serotypes functionally defines subgroups.

Authors:  Joseph E Rabinowitz; Dawn E Bowles; Susan M Faust; Julie G Ledford; Scott E Cunningham; R Jude Samulski
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

5.  Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno-associated virus vectors.

Authors:  Clare E Thomas; Theresa A Storm; Zan Huang; Mark A Kay
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

6.  Directing integrin-linked endocytosis of recombinant AAV enhances productive FAK-dependent transduction.

Authors:  Paul M Kaminsky; Nicholas W Keiser; Ziying Yan; Diana C M Lei-Butters; John F Engelhardt
Journal:  Mol Ther       Date:  2012-01-10       Impact factor: 11.454

7.  Adeno-associated virus type 2 contains an integrin alpha5beta1 binding domain essential for viral cell entry.

Authors:  Aravind Asokan; Julie B Hamra; Lakshmanan Govindasamy; Mavis Agbandje-McKenna; Richard J Samulski
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

8.  Identification of a heparin-binding motif on adeno-associated virus type 2 capsids.

Authors:  A Kern; K Schmidt; C Leder; O J Müller; C E Wobus; K Bettinger; C W Von der Lieth; J A King; J A Kleinschmidt
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 9.  Gene therapy using adeno-associated virus vectors.

Authors:  Shyam Daya; Kenneth I Berns
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

10.  Adeno-associated virus site-specific integration and AAVS1 disruption.

Authors:  Henry Hamilton; Janette Gomos; Kenneth I Berns; Erik Falck-Pedersen
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.